XFOR is the official stock ticker symbol for X4 Pharmaceuticals, Inc., a biopharmaceutical enterprise publicly traded on the NASDAQ exchange. The company specializes in the discovery, development, and commercialization of innovative therapeutics designed to improve the lives of patients suffering from rare hematology diseases, immune system disorders, and specialized conditions regulated by CXCR4 biology.